Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors
- Jinhyuk Bhin
- , Mariana Paes Dias
- , Ewa Gogola
- , Frank Rolfs
- , Sander R. Piersma
- , Roebi de Bruijn
- , Julian R. de Ruiter
- , Bram van den Broek
- , Alexandra A. Duarte
- , Wendy Sol
- , Ingrid van der Heijden
- , Christina Andronikou
- , Taina S. Kaiponen
- , Lara Bakker
- , Cor Lieftink
- , Ben Morris
- , Roderick L. Beijersbergen
- , Marieke van de Ven
- , Connie R. Jimenez
- , Lodewyk F. A. Wessels*
*Corresponding author for this work
- Netherlands Cancer Institute
- Yonsei University
- University of Bern
- University of Bern, Institute of Animal Pathology
Research output: Contribution to journal › Article › Academic › peer-review
31
Downloads
(Pure)